OraSure Technologies, Inc. (NASDAQ:OSUR)

CAPS Rating: 2 out of 5

The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.

Results 1 - 20 of 40 : 1 2 Next »

Recs

0
Member Avatar eldemonio (97.96) Submitted: 9/25/2013 2:08:19 PM : Outperform Start Price: $6.16 OSUR Score: +43.65

OraSure? OraWhythehellnot!

With ObamaCare coming - in lab testing will fall by the wayside as we all start relying on cheaper in-home spit testing.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:48:21 PM : Underperform Start Price: $5.30 OSUR Score: -68.84

Short. Losses widening as they sell more.

Recs

2
Member Avatar zzlangerhans (99.84) Submitted: 8/21/2013 3:17:10 AM : Underperform Start Price: $5.35 OSUR Score: -66.54

The verdict is in on OraQuick In-Home HIV. The launch has failed. Not enough people want to find out if they are HIV+ in the comfort of their own homes. I was overly optimistic myself and got burned on CAPS for it. Now there really isn't much reason to own the stock, but the share price has been on an upward tear since the latest revenue numbers were reported. I didn't see anything that exciting in the numbers except a slight uptick in DNA Genotek revenues, and the company is still losing money without anything exciting on the horizon.

Recs

0
Member Avatar Johnwzee (60.16) Submitted: 10/9/2012 4:50:12 PM : Outperform Start Price: $10.59 OSUR Score: -47.22

A private way to check out your sexual health

Recs

0
Member Avatar BillZack (< 20) Submitted: 9/29/2012 1:45:13 PM : Outperform Start Price: $11.25 OSUR Score: -52.57

Delivery to market. Should finally start to see some payoff to investors.

Recs

0
Member Avatar stan68ar (90.69) Submitted: 5/21/2012 12:51:51 PM : Outperform Start Price: $10.78 OSUR Score: -63.11

HIV test approval and buyout target

Recs

0
Member Avatar beachboy235 (< 20) Submitted: 4/18/2012 5:25:48 PM : Outperform Start Price: $10.40 OSUR Score: -51.22

The OTC market can b huge and approval is around the courner

Recs

0
Member Avatar BuffettJunior1 (97.65) Submitted: 10/16/2011 7:03:24 PM : Underperform Start Price: $9.04 OSUR Score: +58.10

WOW! Now this stock is overvalued!

When you subtract stock based compensation from free cash flow you begin to see just how unprofitable this company is. Only those who don't know what they are doing would invest in this terrible company.

Recs

0
Member Avatar emubob (< 20) Submitted: 4/10/2011 5:13:20 AM : Outperform Start Price: $8.60 OSUR Score: -36.92

growing industry

Recs

0
Member Avatar hunterjumper (< 20) Submitted: 11/26/2010 8:56:32 PM : Outperform Start Price: $4.99 OSUR Score: +30.28

Looks like this company is finally on track to get approvals for both of its best prospective tests which will save or lengthen lives.

Recs

0
Member Avatar LittleChinaGirl (< 20) Submitted: 11/22/2010 4:09:34 PM : Outperform Start Price: $4.92 OSUR Score: +33.60

nicht ein wiederkauf

Recs

2
Member Avatar EDGAOSCHULTHEIS (< 20) Submitted: 3/18/2009 11:37:43 AM : Outperform Start Price: $2.73 OSUR Score: +102.81

Management has underperformed in nearly every aspect in the past 4 years. Sales have fallen as products underperformed and continued delays in FDA approval of OTC oraquick product.

The fiest quarter of 2009 should prove the low point in company sales and earnings. Cryo produces are once again being dstributed (all be it in a limited form) after a year without distribution. FDA approval of HEP C should take place later this year and the light at the end of the (FDA OTC) approval for oraquick.

The market will discount these new revenue streams within the next few months (normally 6-9 months prior to FDA approval.

The company has nearly 1.62 / share net working capital and only trades about $1.00 above that level.

This is my first rating on CAPS so take everything with a grain of salt.

good luck

Do your own research

Recs

1
Member Avatar sammeda (< 20) Submitted: 3/9/2009 8:02:09 PM : Outperform Start Price: $2.34 OSUR Score: +134.29

Hiv testing should be given priority

Recs

1
Member Avatar biovestor (< 20) Submitted: 6/28/2008 7:02:41 AM : Outperform Start Price: $3.94 OSUR Score: +92.82

Beaten down recently on concerns over its HIV test and legal issues, but still has excellent prospects for its over-the-counter oral fluid HIV test and its hepatitis C test for healthcare professionals.

Recs

0
Member Avatar TheRupturedDuck (35.72) Submitted: 4/16/2008 10:46:21 PM : Underperform Start Price: $6.94 OSUR Score: +10.38

From my short ideas/valuation screen

Recs

0
Member Avatar H3rbaLif3 (68.79) Submitted: 3/28/2008 4:28:21 AM : Outperform Start Price: $7.49 OSUR Score: -25.04

HIV test in 20 minutes is amazing in this day and age where faster and easier is better

Recs

0
Member Avatar primetangent (49.66) Submitted: 2/21/2008 6:49:40 PM : Outperform Start Price: $7.03 OSUR Score: -14.49

Hometown company, but yea they have the hiv oral testing which is good, but cant wait for their products in the pipeline.

Recs

0
Member Avatar pinkey21 (41.65) Submitted: 8/11/2007 5:35:18 AM : Outperform Start Price: $9.60 OSUR Score: -42.42

No blood or urine needed. Aids amd drug testing made simple and cheap. This is a definite take over down the road.

Recs

0
Member Avatar ayarber3 (24.28) Submitted: 6/4/2007 4:45:52 PM : Outperform Start Price: $7.77 OSUR Score: -10.83

watch the charts

Recs

0
Member Avatar rzipper1 (< 20) Submitted: 5/29/2007 1:48:56 AM : Outperform Start Price: $7.60 OSUR Score: -9.57

Oral over-the-counter HIV test is going to be approved in one year. Oral test for drugs will start making large in roads into the market share for job drug testing

Results 1 - 20 of 40 : 1 2 Next »

Featured Broker Partners


Advertisement